Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Search Contacts Login 
  • Users Online: 294
  • Home
  • Print this page
  • Email this page


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2022  |  Volume : 34  |  Issue : 2  |  Page : 122-125

Genetic polymorphism of carcinogen metabolic enzymes in oral submucous fibrosis


1 Department of Oral Medicine and Radiology, Government Dental College, Trivandrum, India
2 Research Regional Cancer Center, Medical College, Trivandrum, India
3 Kerala University of Health Sciences, Thrissur, Kerala, India

Date of Submission25-Jul-2021
Date of Decision03-May-2022
Date of Acceptance05-May-2022
Date of Web Publication22-Jun-2022

Correspondence Address:
Sunu Ramachandran
Sarovaram, PRRA 23, Charuvila Lane, Pazhaya Road, Medical College, Thiruvananthapuram, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jiaomr.jiaomr_209_21

Rights and Permissions
   Abstract 


Background: Biotransformation plays a crucial role in carcinogen activity. Genetic polymorphisms in xenobiotic-metabolizing enzymes crucial to a carcinogen and drug metabolism lead to variations in their activity. These enzymes increase cancer risk by an altered action on environmental carcinogens. The objective of this study was to analyze the significance of genetic polymorphisms in CYP1A1 and GSTM1 (carcinogen-metabolizing enzymes) genes in patients with oral submucous fibrosis (OSMF). Method: The study subjects included 50 patients. Twenty-five were diagnosed with OSMF, 5 with malignant transformation in OSMF, and 20 age and sex-matched healthy controls. Genotypes of CYP1A1 and GSTM1 were determined by polymerase chain reaction-restricted frequency length polymorphism. Results: 10%, 40%, and 60% GSTM1 null genotype were observed in normal subjects, OSMF patients, and OSMF patients with malignancy, respectively. 15%, 48%, and 40% CYP1A1 polymorphism were noted in normal subjects, OSMF patients, and OSMF with malignancy, respectively. Conclusion: Polymorphism in CYP1A1 and GSTM1 null genotype may increase the risk of OSMF. Combined polymorphisms may be an increased risk factor than single-gene polymorphism.

Keywords: CYP1A1, genetic polymorphism, GSTM1, oral submucous fibrosis


How to cite this article:
Ramachandran S, Balan A, Bose C T, Balaram P, Nityasri V. Genetic polymorphism of carcinogen metabolic enzymes in oral submucous fibrosis. J Indian Acad Oral Med Radiol 2022;34:122-5

How to cite this URL:
Ramachandran S, Balan A, Bose C T, Balaram P, Nityasri V. Genetic polymorphism of carcinogen metabolic enzymes in oral submucous fibrosis. J Indian Acad Oral Med Radiol [serial online] 2022 [cited 2022 Dec 7];34:122-5. Available from: http://www.jiaomr.in/text.asp?2022/34/2/122/347915




   Introduction Top


Oral cancer is one of the most prevalent cancers in India and Southeast Asia, accounting for about 40% of all malignancies.[1],[2] A vast majority of cancers are due to exposure to various environmental agents, which can change the structure and function of genes involved in the growth and development of cells. Most oral cancers are linked to common genetic alterations such as p53, prb, Cyclin D1, Cytochrome P 450, GST, p16 p21, etc. They identify specific biomarkers for oral cancer progression from premalignant lesions such as leukoplakia and oral submucous fibrosis (OSMF) to malignant stages.

The role of gene-environment interactions in disease pathogenesis has been often debated. Several studies indicate that polymorphisms in genes encoding enzymes involved in the metabolism of tobacco, alcohol, and other environmental factors may be linked to individual susceptibility to oral cancers.[3],[4],[5],[6] The gene-environment interactions in carcinogenesis are explained by Phase I (cytochrome p450) and Phase II (Glutathione S Transferases) enzymes involved in the metabolism of carcinogens.

Genetic polymorphisms are widespread and play a major role in human diseases. The superfamilies of cytochrome p450 (phase I) enzymes catalyze the oxidative metabolism of most endogenous and exogenous chemicals. For CYP1A1 polymorphism, a T to C transition in the 30 noncoding regions (a thymine/cytosine point mutation) has been confirmed to be related to the high risk of lung and head and neck cancers. In addition, CYP1A1 polymorphism, an amino acid substitution from isoleucine to valine at codon 462, shows the effects of enhancing catalytic activity and increasing the risk for lung cancer.[7],[8] For glutathione-S-transferase M1(GSTM1), the polymorphism includes the present genotype and null genotype, which are associated with the abnormal function of GSTM1 enzyme, an important member in the detoxification of carcinogens in tobacco smoking.[9]

This study aimed at determining whether the presence of genetic polymorphism of CYP1A1 genes and GSTM1 genes predisposes patients to OSMF and subsequent malignant transformation.


   Methodology Top


The study was conducted in the Department of Oral Medicine and Radiology in collaboration with the division of cancer research, Regional Cancer Center, Thiruvananthapuram, for 2 years. The study was approved by the Hospital Ethics Committee/Institutional Review Board NO: HEC/IRB/05 dtd 28/05/2005 and by Helsinki consideration. Good clinical practice guidelines were followed. Written informed consent was obtained from every participant. The sample size was calculated using the formula 4pq/d2, where p is the proportion of patients with Cyp1A1 genetic polymorphism, q is 100-p, and d is the precision taken as 20%. Thus, the minimum sample size required was 25. The patients who reported to the outpatient clinic were screened for the features suggestive of OSMF, and their clinical data were documented. Thirty patients were selected for the study based on OSF's clinical and histopathological features, in which malignant transformation and significant polymorphism were observed in five patients; hence, they were grouped separately. Twenty patients were only selected for normal samples because obtaining consent from those groups was difficult. Hence, fifty patients selected for the study after obtaining the written consent were grouped into Normal, OSF, and OSF with malignancy. Tissue samples and 2 mL of peripheral venous blood were collected from the arm vein in a heparinized test tube for normal and OSMF patients. Genomic DNA was checked using 0.8% agarose gel electrophoresis. The genetic polymorphisms of CYP1A1 and GSTM1 were analyzed by polymerase chain reaction-restricted frequency length polymorphism using specific primers. Beta globin was used as internal control and amplified in all the samples. Bands for GSTM1 and CYP1A1 genes were observed using a gel doc system [Figure 1] and [Figure 2]. Statistical analysis was performed using SPSS. The various parameters were compared using Chi-square tests. The association of observed values and clinical parameters was assessed using a one-way analysis of variance (ANOVA).
Figure 1: GSTM1 deletion in oral submucous fibrosis

Click here to view
Figure 2: CYP1A1 detection in OSMF

Click here to view



   Results Top


The age of the study subjects ranged from 25–75 years, with a slight female predominance. In the normal group, only two patients had habit of chewing. All patients diagnosed with OSF and OSF with malignancy had the habit of betel quid chewing and exhibited a higher frequency and longer duration of betel quid chewing, many of whom were chewers of commercial tobacco preparations. 10% of the OSF patients included in the study were also diagnosed with a leukoplakic patch on the tongue.

In this study, GSTM1 polymorphism was observed in normal subjects, OSF patients, and OSF patients at 10%, 44%, and 60%, respectively [Table 1] and [Figure 3]. Using Chi-square analysis, it was noted that genetic polymorphism was higher in the subjects diagnosed with OSF when compared to normal groups and the difference was statistically significant (P-value - 0.013). Among subjects of both OSF and OSF with malignant transformation groups, many females showed genetic polymorphism. Significantly, it was also observed that all subjects with GSTM1 polymorphism were habitual chewers of tobacco preparation. Among the 30 OSF subjects, including those with malignancy, it was observed that three had oral leukoplakia. Among the three patients, polymorphism was observed in two patients, and both of them were only GSTM1 polymorphic.
Figure 3: GSTM1 polymorphism

Click here to view
Table 1: Distribution of GSTM1 polymorphism

Click here to view


With the help of a gel doc system, the study observed 15% CYP1A1 polymorphism in normal samples, 48% polymorphism in OSF samples, and 40% polymorphism in OSF with Ca samples [Table 2] and [Figure 4]. Compared to the frequency of genetic polymorphism between OSF and normal cases, the genetic polymorphism was significantly higher in OSF than in controls (P-value 0.02). It was observed that none of the three patients with leukoplakia showed CYP1A1 polymorphism, contrary to the observations of the presence of GSTM1 polymorphism. The twenty-five OSF patients were divided into early, moderate, and advanced grades according to the histopathologic grading criteria of Sirsat and Pindborg.[10] The study noted an increased expression of polymorphism in moderate cases. Among the twenty five patients, eight showed only GSTM1 deletion, nine were only CYPA1 polymorphic, and three showed combined polymorphism.
Figure 4: CYP1A1 polymorphism

Click here to view
Table 2: Distribution of CYP1A1 polymorphism

Click here to view



   Discussion Top


Epidemiological studies have demonstrated a remarkable influence of various harmful habits in developing oral cancer. OSMF is one of the most common oral premalignant conditions. The role of gene-environment interaction in carcinogenesis has recently gained much interest. Several studies indicate that polymorphisms in genes encoding enzymes that are involved in the metabolism of carcinogens present in tobacco smoke, alcohol, and other environmental factors may be linked to individual susceptibility to oral cancer.[11] Carcinogen-metabolizing enzymes are expressed in oral mucosa, suggesting that carcinogen metabolism could occur at this site.[12] Differences in enzyme activity in the oral cavity could represent one mechanism by which oral cancers and precancers occur.

Polymorphism in CYP1A1 and GSTM1 null genotypes may increase the risk of OSMF. Sreelekha et al.,[13] who conducted a similar study, suggested that polymorphism of CYP1A1 and GSTM1 null genotype in Indian subjects may confer an increased risk of cancers of the oral cavity. Genetic polymorphism and increased lifetime exposure to various environmental factors may pose a greater threat to OSF. An extensive review did not show any association between genotypes and sex. GSTM1 null genotype may increase the risk of developing leukoplakia more than CYP1A1 polymorphism.[14] It was observed in the present study that of the 29 habitués with genetic polymorphism, 24 persons had developed OSF, of whom four had malignancy also. Notably, 82.7% of persons with genetic polymorphism exposed to carcinogens had developed OSF [Table 3] and [Table 4]. Thus, it may be proposed that genetic factors and the betel quid's carcinogenic potential may increase the risk of developing oral cancers and precancers. Seedat and Van Wyk, in their series on OSF in Durban Indians with and without the habit of chewing pan, suggested genetic predisposition for the occurrence of OSF.[15],[16] CYP1A1 polymorphism results in increased metabolic activity, whereas the null genotype of GSTM1 has decreased capability to detoxify some carcinogens. As a result of polymorphisms, the number of carcinogens present in the body increases, leading to the development of cancers and precancers. Therefore, it may be suggested that the balance between CYP and GST enzymes may substantially influence cancer risk. A longer duration of deleterious oral habits in polymorphic patients contributes to oral carcinogenesis. Little et al.[17] had advocated that the occurrence of oral premalignant lesions and malignancies depends on the amount, frequency, and duration of betel quid chewing.
Table 3: Correlation of habit with GSTM1 polymorphism

Click here to view
Table 4: Correlation of habit with CYP1A1 polymorphism

Click here to view


Subjects with combined polymorphism are probably at an increased risk. Sato et al.[18] indicated that combined genotyping of CYP1A1 and GSTM1 genes revealed higher relative risk than that ascribed to a single gene, particularly those at low cigarette dose levels. In conclusion, our results revealed that the null genotype of GSTM1 influences the risk of developing OSF. It has been reported that GSTM1 is involved in detoxifying polycyclic aromatic hydrocarbons and other mutagens. Cells from GSTM1 null individuals are more susceptible to DNA damage caused by these agents.[19] At the same time, Chaudhuri et al.[20] showed an increased risk for OSMF in CYP1A1 in Eastern India.

The limitation of our study was we had only five patients with OSMF with malignancy. OSF development is multifactorial; additional environmental and genetic parameters could also be risk factors. Thus, further studies on larger sample sizes and different populations need to be carried out to assess the accurate role of the carcinogen-metabolizing enzyme, especially Cyp1A1, as a risk factor for developing OSF and malignancy.


   Conclusion Top


This study showed that the polymorphism of CYP1A1 and GSTM1 null genotype might increase the risk of developing OSMF. Accumulation of such information on individual susceptibility to certain types of cancers will be valuable for identifying high-risk individuals and preventing the possible development of cancer by reducing the intake of carcinogenic substances and introducing chemo-preventive measures.

Declaration of patient

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Acknowledgements

We want to thank all the study participants for taking part in the study. We express our gratitude to Mrs. Sreelekha, the Research Scientist, and other staff and students in the division of cancer research, RCC, Trivandrum, for their support and contribution in conducting this study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Sankaranarayanan R, Moinudeen MN, Nair MK Padmanabhan TK. Etiology of oral cancer in patients less than 30 years of age. Br J Cancer 1989;59:439-40.  Back to cited text no. 1
    
2.
Sankaranarayanan R. Oral cancer in India: An epidemiological and clinical review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1990;69:32530.  Back to cited text no. 2
    
3.
Liu H, Jia J, Mao X, Lin Z. Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility-A Meta-Analysis. Medicine 2015;94:e895. doi: 10.1097/MD.0000000000000895  Back to cited text no. 3
    
4.
Liu CJ, Chang CS, Lui MT, Dang CW, Shih YH, Chang KW. Association of GST genotypes with the age of onset and lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med 2005;34:473-77.  Back to cited text no. 4
    
5.
Jhavar S, Sarin R, Mulherkar R, Benner A, Agarwal JP, Dinshaw K. Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract in Indian males using tobacco. Oral Oncol 2004;40:84-91.  Back to cited text no. 5
    
6.
Drummond SN, De Marco L, Noronha JC, Gomez RS. GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol 2004;40:52-5.  Back to cited text no. 6
    
7.
Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-17.  Back to cited text no. 7
    
8.
Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, Park KK, Polymorphism of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 2007;48:233-9.  Back to cited text no. 8
    
9.
Masood N, Yasmin A, Kayani MA. Genetic deletions of GSTM1 and GSTT1 in head and neck cancer: Review of the literature from 2000 to 2012. Asian Pac J Cancer Prev 2013;14:3535-9.  Back to cited text no. 9
    
10.
Sirsat SM, Pindborg JJ. Sub epithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 1967;70:161-73.  Back to cited text no. 10
    
11.
Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, et al. Oral squamous cell cancer: Early detection and the role of alcohol and smoking. Head Neck Oncol 2011;3:2.  Back to cited text no. 11
    
12.
Reichart PA, Nguyen XH. Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: A review. J Oral Pathol Med 2008;37:511-4.  Back to cited text no. 12
    
13.
Sreelekha TT, Ramdas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001;37:593-8.  Back to cited text no. 13
    
14.
Duarte EC, da Silva MS, Gomez MV, Gomez RS. GSTM1 polymorphism and oral leukoplakia. J Oral Pathol Med 2006;35:202-5.  Back to cited text no. 14
    
15.
Seedat HA, Van Wyk CW. Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer. S Afr Med J 1988;74:572-5.  Back to cited text no. 15
    
16.
Seedat HA, Van Wyk CW. Betel nut chewing and submucous fibrosis in Durban. S Afr Med J 1988;74:568-71.  Back to cited text no. 16
    
17.
Little SJ, Stevens VJ, Lachance PA, Serverson HH, Bartely MH, Lichenstein E, et al. Smokeless tobacco habits and oral lesions in dental patients. J Public Health Dent 1992;52:269-76.  Back to cited text no. 17
    
18.
Sato M, Sato T, Izumo T, Amagasa T. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 gene. Oral Oncol 2000;36:267-71.  Back to cited text no. 18
    
19.
Agarwal D, Gupta S, Agarwal D. Role of GSTM1 and GSTT1 polymorphism: Susceptibility to oral submucous fibrosis in the North Indian population. Oncology 2010;79:181-6.  Back to cited text no. 19
    
20.
Chaudhuri SR, Mukherjee S, Paul RR, Haldar A, Chaudhuri K. CYP1A1 and CYP2E1 gene polymorphisms may increase succeptibility to Oral submucous fibrosis among betel quid chewers of Eastern India. Gene 2013;513:268-71.  Back to cited text no. 20
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

   Abstract Introduction Methodology Results Discussion Conclusion Article Figures Article Tables
  In this article
 References

 Article Access Statistics
    Viewed1161    
    Printed90    
    Emailed0    
    PDF Downloaded258    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]